- Home
- NBIX vs IAG Comparison
NBIX vs IAG Comparison
Compare NBIX & IAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBIX | IAG |
|---|---|---|
| Founded | 1992 | 1990 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 13.1B |
| IPO Year | 1996 | 2002 |
Fundamental Metrics
Financial Performance| Metric | NBIX | IAG |
|---|---|---|
| Price | $128.55 | $21.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 22 | 4 |
| Target Price | ★ $175.23 | $17.75 |
| AVG Volume (30 Days) | 1.2M | ★ 6.9M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.95 | N/A |
| EPS | ★ 4.67 | N/A |
| Revenue | ★ $161,626,000.00 | N/A |
| Revenue This Year | $22.85 | $44.84 |
| Revenue Next Year | $9.99 | $1.33 |
| P/E Ratio | $27.75 | ★ $18.66 |
| Revenue Growth | ★ 977.51 | N/A |
| 52 Week Low | $84.23 | $5.35 |
| 52 Week High | $160.18 | $24.87 |
Technical Indicators
Market Signals| Indicator | NBIX | IAG |
|---|---|---|
| Relative Strength Index (RSI) | 42.79 | 49.99 |
| Support Level | $122.82 | $16.22 |
| Resistance Level | $128.99 | $22.47 |
| Average True Range (ATR) | 2.97 | 0.98 |
| MACD | 0.12 | -0.31 |
| Stochastic Oscillator | 23.91 | 22.27 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About IAG Iamgold Corporation
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Cote Gold mine - Canada, Burkina Faso - Essakane mine, Westwood mine - Canada. The company's s non-gold mine segments are Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Cote Gold mine segment.